Dengue fever vaccine: Towards low cost production and delivery

登革热疫苗：实现低成本生产和交付

• 批准号: nhmrc : 1074296
• 负责人: Dr Melanie Oey
• 金额: $ 40.81万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Development Grants
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/dengue-fever-vaccine-production-delivery/455586
• 关键词: Dengue; fever; vaccine; Towards; low

With rising populations and a warming climate mosquito borne viral diseases will become more prevalent and low-cost vaccine production & delivery systems will become increasingly important. Here a microalgae based vaccine production platform will be coupled to proven Nanopatch & low cost oral vaccine delivery. The focus is on a Dengue virus vaccine, as Dengue causes 400 million infections & 100 million symptomatic cases annually.

随着人口增长和气候变暖，蚊媒病毒性疾病将变得更加普遍，低成本的疫苗生产和交付系统将变得越来越重要。在这里，基于微藻的疫苗生产平台将与经过验证的纳米贴片和低成本口服疫苗相结合。重点是登革热病毒疫苗，因为登革热每年造成4亿感染和1亿有症状病例。